Answers are grounded in this paper and cite their sources.
Backgroud: Rhinovirus (RV) infection is a major trigger of asthma exacerbations, yet targeted therapies for virus-induced exacerbations remain lacking. Although impaired interferon responses have been proposed to underlie increased susceptibility to viral infections in asthma, findings remain inconsistent. Objective: We aimed to investigate the magnitude and temporal dynamics of primary human nasal epithelial inflammatory and antiviral responses to RV infection in asthma. Methods: Primary human nasal epithelial cells (hNECs) derived from asthmatic and healthy donors were infected with rhinovirus 1B (RV1B). Cytokine production, interferon responses, interferon-stimulated gene expression, and viral RNA levels were assessed at multiple time points following infection. Intracellular reactive oxygen species (ROS) levels were measured using the DCFDA assay. Transcriptomic profiling was performed 6 h post-infection. Results: RV1B infection persisted for at least 48 h post-infection and induced robust inflammatory and antiviral responses in both asthmatic and healthy hNECs. Asthmatic epithelial cells exhibited enhanced IL-6 responses at 24 h post-infection, whereas IL-29/IFN-λ1 mRNA expression showed a transient pattern, declining over time despite persistent viral RNA levels. In contrast, IFN-λ (IL-29/IL-28B) protein, IL-8, IL-1β, MCP-1, and the interferon-stimulated gene OAS1 remained elevated. Transcriptomic analysis revealed enhanced immune-associated signaling together with reduced expression of genes involved in epithelial homeostasis and repair in asthmatic epithelial cells following RV infection. Conclusions: Nasal epithelial responses to RV infection in asthma are not simply impaired, but dysregulated, with preserved antiviral capacity but altered coordination between inflammatory, antiviral, and structural pathways. These findings highlight the importance of temporal coordination and pathway integration, and suggest that restoring epithelial balance may represent a targeted strategy for reducing virus-induced asthma exacerbations.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: